2 trial results announced this day (US Eastern).
| Time (ET) | Drug / result | Company | Outcome | Before | 24h later | 24h move |
|---|---|---|---|---|---|---|
| 6:37 AM | Zumilokibart Atopic Dermatitis | Apogee Therapeutics (APGE) | Met | $82.81 | $77.75 | −6.11% |
| 4:34 PM | ublituximab Relapsing Forms of Multiple Sclerosis | TG Therapeutics (TGTX) | Met | $39.20 | $38.82 | −0.97% |
For information only. Not investment or medical advice. Prices are historical, from consolidated market data, and may contain errors. Always check the original source.